Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1989 1
1990 2
1991 2
1992 1
1993 2
1994 6
1995 1
1996 6
1997 3
1998 1
1999 5
2000 1
2002 2
2003 4
2004 1
2005 2
2006 2
2007 6
2008 3
2009 7
2010 4
2011 7
2012 10
2013 16
2014 15
2015 16
2016 14
2017 14
2018 8
2019 11
2020 23
2021 17
2022 18
2023 24
2024 14

Text availability

Article attribute

Article type

Publication date

Search Results

227 results

Results by year

Filters applied: . Clear all
Page 1
Monoallelic IFT140 pathogenic variants are an important cause of the autosomal dominant polycystic kidney-spectrum phenotype.
Senum SR, Li YSM, Benson KA, Joli G, Olinger E, Lavu S, Madsen CD, Gregory AV, Neatu R, Kline TL, Audrézet MP, Outeda P, Nau CB, Meijer E, Ali H, Steinman TI, Mrug M, Phelan PJ, Watnick TJ, Peters DJM, Ong ACM, Conlon PJ, Perrone RD, Cornec-Le Gall E, Hogan MC, Torres VE, Sayer JA; Genomics England Research Consortium, the HALT PKD, CRISP, DIPAK, ADPKD Modifier, and TAME PKD studies; Harris PC. Senum SR, et al. Among authors: ong acm. Am J Hum Genet. 2022 Jan 6;109(1):136-156. doi: 10.1016/j.ajhg.2021.11.016. Epub 2021 Dec 9. Am J Hum Genet. 2022. PMID: 34890546 Free PMC article.
An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease International.
Müller RU, Messchendorp AL, Birn H, Capasso G, Cornec-Le Gall E, Devuyst O, van Eerde A, Guirchoun P, Harris T, Hoorn EJ, Knoers NVAM, Korst U, Mekahli D, Le Meur Y, Nijenhuis T, Ong ACM, Sayer JA, Schaefer F, Servais A, Tesar V, Torra R, Walsh SB, Gansevoort RT. Müller RU, et al. Among authors: ong acm. Nephrol Dial Transplant. 2022 Apr 25;37(5):825-839. doi: 10.1093/ndt/gfab312. Nephrol Dial Transplant. 2022. PMID: 35134221 Free PMC article. Clinical Trial.
Patient Perspectives on ADPKD.
Gittus M, Harris T, Ong AC. Gittus M, et al. Among authors: ong ac. Adv Kidney Dis Health. 2023 May;30(3):294-302. doi: 10.1053/j.akdh.2023.01.002. Adv Kidney Dis Health. 2023. PMID: 37088530 Free article. Review.
Cellular signaling in PKD: foreword.
Torres VE, Ong ACM. Torres VE, et al. Among authors: ong acm. Cell Signal. 2020 Jul;71:109625. doi: 10.1016/j.cellsig.2020.109625. Epub 2020 Apr 2. Cell Signal. 2020. PMID: 32247773 Free article.
Rare disease gene association discovery from burden analysis of the 100,000 Genomes Project data.
Cipriani V, Vestito L, Magavern EF, Jacobsen JO, Arno G, Behr ER, Benson KA, Bertoli M, Bockenhauer D, Bowl MR, Burley K, Chan LF, Chinnery P, Conlon P, Costa M, Davidson AE, Dawson SJ, Elhassan E, Flanagan SE, Futema M, Gale DP, García-Ruiz S, Corcia CG, Griffin HR, Hambleton S, Hicks AR, Houlden H, Houlston RS, Howles SA, Kleta R, Lekkerkerker I, Lin S, Liskova P, Mitchison H, Morsy H, Mumford AD, Newman WG, Neatu R, O'Toole EA, Ong AC, Pagnamenta AT, Rahman S, Rajan N, Robinson PN, Ryten M, Sadeghi-Alavijeh O, Sayer JA, Shovlin CL, Taylor JC, Teltsh O, Tomlinson I, Tucci A, Turnbull C, van Eerde AM, Ware JS, Watts LM, Webster AR, Westbury SK, Zheng SL, Caulfield M, Smedley D. Cipriani V, et al. Among authors: ong ac. medRxiv [Preprint]. 2023 Dec 21:2023.12.20.23300294. doi: 10.1101/2023.12.20.23300294. medRxiv. 2023. PMID: 38196618 Free PMC article. Preprint.
Venglustat, a Novel Glucosylceramide Synthase Inhibitor, in Patients at Risk of Rapidly Progressing ADPKD: Primary Results of a Double-Blind, Placebo-Controlled, Phase 2/3 Randomized Clinical Trial.
Gansevoort RT, Hariri A, Minini P, Ahn C, Chapman AB, Horie S, Knebelmann B, Mrug M, Ong ACM, Pei YPC, Torres VE, Modur V, Antonshchuk I, Perrone RD. Gansevoort RT, et al. Among authors: ong acm. Am J Kidney Dis. 2023 May;81(5):517-527.e1. doi: 10.1053/j.ajkd.2022.10.016. Epub 2022 Dec 17. Am J Kidney Dis. 2023. PMID: 36535535 Free article. Clinical Trial.
Endothelin and tubulointerstitial renal disease.
Ong AC, von Websky K, Hocher B. Ong AC, et al. Semin Nephrol. 2015 Mar;35(2):197-207. doi: 10.1016/j.semnephrol.2015.03.004. Semin Nephrol. 2015. PMID: 25966351 Review.
How simple are 'simple renal cysts'?
Simms RJ, Ong AC. Simms RJ, et al. Among authors: ong ac. Nephrol Dial Transplant. 2014 Sep;29 Suppl 4(Suppl 4):iv106-12. doi: 10.1093/ndt/gfu106. Nephrol Dial Transplant. 2014. PMID: 25165175 Free PMC article. Review.
Chronic kidney disease and the global public health agenda: an international consensus.
Francis A, Harhay MN, Ong ACM, Tummalapalli SL, Ortiz A, Fogo AB, Fliser D, Roy-Chaudhury P, Fontana M, Nangaku M, Wanner C, Malik C, Hradsky A, Adu D, Bavanandan S, Cusumano A, Sola L, Ulasi I, Jha V; American Society of Nephrology; European Renal Association; International Society of Nephrology. Francis A, et al. Among authors: ong acm. Nat Rev Nephrol. 2024 Apr 3. doi: 10.1038/s41581-024-00820-6. Online ahead of print. Nat Rev Nephrol. 2024. PMID: 38570631 Free article. Review.
A panel of diverse Klebsiella pneumoniae clinical isolates for research and development.
Martin MJ, Stribling W, Ong AC, Maybank R, Kwak YI, Rosado-Mendez JA, Preston LN, Lane KF, Julius M, Jones AR, Hinkle M, Waterman PE, Lesho EP, Lebreton F, Bennett JW, Mc Gann PT. Martin MJ, et al. Among authors: ong ac. Microb Genom. 2023 May;9(5):mgen000967. doi: 10.1099/mgen.0.000967. Microb Genom. 2023. PMID: 37141116 Free PMC article.
227 results